JP6595102B2 - 眼内レンズ組立体 - Google Patents
眼内レンズ組立体 Download PDFInfo
- Publication number
- JP6595102B2 JP6595102B2 JP2018514750A JP2018514750A JP6595102B2 JP 6595102 B2 JP6595102 B2 JP 6595102B2 JP 2018514750 A JP2018514750 A JP 2018514750A JP 2018514750 A JP2018514750 A JP 2018514750A JP 6595102 B2 JP6595102 B2 JP 6595102B2
- Authority
- JP
- Japan
- Prior art keywords
- contact portion
- intraocular lens
- peripheral surface
- equator
- section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000033001 locomotion Effects 0.000 claims description 98
- 230000002093 peripheral effect Effects 0.000 claims description 66
- 230000005540 biological transmission Effects 0.000 claims description 52
- 239000002775 capsule Substances 0.000 claims description 32
- 230000001737 promoting effect Effects 0.000 claims description 29
- 239000002131 composite material Substances 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 18
- 230000000994 depressogenic effect Effects 0.000 claims description 10
- 210000005252 bulbus oculi Anatomy 0.000 claims description 9
- 210000001508 eye Anatomy 0.000 claims description 9
- 230000008878 coupling Effects 0.000 claims description 8
- 238000010168 coupling process Methods 0.000 claims description 8
- 238000005859 coupling reaction Methods 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims 1
- 210000000695 crystalline len Anatomy 0.000 description 202
- 230000001886 ciliary effect Effects 0.000 description 48
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 13
- 102100026735 Coagulation factor VIII Human genes 0.000 description 12
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 12
- 210000001747 pupil Anatomy 0.000 description 10
- -1 polydimethylsiloxane Polymers 0.000 description 8
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000000017 hydrogel Substances 0.000 description 6
- 210000003190 lens capsule crystalline Anatomy 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 5
- 239000004926 polymethyl methacrylate Substances 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 4
- 208000002177 Cataract Diseases 0.000 description 3
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000001491 myopia Diseases 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 201000010041 presbyopia Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- JGSGDKQAIBNOAQ-UHFFFAOYSA-N C(CCC)(=O)C(C(=O)O)=C.C(C=C)(=O)O Chemical compound C(CCC)(=O)C(C(=O)O)=C.C(C=C)(=O)O JGSGDKQAIBNOAQ-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 206010027646 Miosis Diseases 0.000 description 1
- 208000006550 Mydriasis Diseases 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 210000004240 ciliary body Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000003547 miosis Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000000914 phenoxymethylpenicillanyl group Chemical group CC1(S[C@H]2N([C@H]1C(=O)*)C([C@H]2NC(COC2=CC=CC=C2)=O)=O)C 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- WPPDXAHGCGPUPK-UHFFFAOYSA-N red 2 Chemical compound C1=CC=CC=C1C(C1=CC=CC=C11)=C(C=2C=3C4=CC=C5C6=CC=C7C8=C(C=9C=CC=CC=9)C9=CC=CC=C9C(C=9C=CC=CC=9)=C8C8=CC=C(C6=C87)C(C=35)=CC=2)C4=C1C1=CC=CC=C1 WPPDXAHGCGPUPK-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000003106 tissue adhesive Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1624—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
- A61F2/1635—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside for changing shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1648—Multipart lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1694—Capsular bag spreaders therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Description
capsular
tention ring)の挿入を容易にする構造や、後嚢の混濁を防止するための構造などに関する研究が行われている。
absorbing polysiloxane)、コラーゲンコポリマー(Collagen copolymer)、金(Gold)、ヒドロゲル(Hydrogel)、HEMA(2−hydroxyethyl methacrylate)、MMA(methyl methacrylate)、CAB(cellulose acetate butylate)、2−HEMA(2−hydroxy ethyl methacrylate)、NVP(n−vinyl pyrrolidone)、PVP(polyvinyl
pyrrolidone)、MA(methacrylic acid)、GMA(glycerol methacrylate)、DMS(dimethyl siloxane)、PHEMA(polyhydroxyethyl methacrylate)、PEGMMA(polyethylenehlycol methacrylate)、ポリHEMAヒドロゲル(Poly HEMA hydrogel)、紫外線吸収ポリHEMAヒドロゲル(Poly HEMA hydrogel with UV absorption)、シリコーンヒドロゲル(Silicone hydrogels)、GMA/HEMA、HEMA/PVP/MA、PVA、HEMA/PVA/MA、HEMA/PVA/MMA、HEMA/MMA、HEMA/NVP、HEMA/NVP/MA、HEMA/NVP/MMA、HEMA/Acryl、及びHEMA/PCなどのうちの少なくも一つが使用できる。
毛様小帯の動きに応じて伝達される力を眼内レンズ30に効率よく伝達しなくなり、3倍を超えて形成する場合には、眼内レンズ30のオプティック部を隠す。このような倍率で構成した場合、外周面11の全長は2mm〜8mmである。
複合運動伝達面が正面投影の際に直線断面をなすように構成されることも可能である。また、弧状をなすか直線断面形状をなす複合運動伝達面20は、それぞれ毛様小帯をなす第2小帯7bの付近に位置することが好ましい。しかし、複合運動伝達面20の位置は、第2小帯7bの付近にのみ限定せずに、第1小帯7aと第2小帯7bとの間のどの位置に形成されても構わず、この状態で第2小帯7bと一部分でも重なるように形成されることが好ましい。複合運動伝達面20が形成される眼内レンズ支持体10は、複合運動伝達面20が陥設され、末端に行くほど益々その断面が縮小される構造で形成されてもよい。
Claims (13)
- 眼球内に挿入される眼内レンズ組立体であって、
前記眼球の水晶体嚢の内部に挿入されるリング状からなり、前記水晶体嚢に接触する外周面(11)は、前記水晶体嚢の前面部に接触する第1前面接触部(11a)と、前記水晶体嚢の後面部に接触する第1後面接触部(11b)とを含み、前記外周面(11)に対向する内周面(12)は、前記第1前面接触部(11a)に対向する第2前面接触部(12a)と、前記第1後面接触部(11b)に対向する第2後面接触部(12b)とを含む眼内レンズ支持体(10);
前記第2前面接触部(12a)の少なくとも一区間に接触する第3前面接触部(52a)と、前記第2後面接触部(12b)の少なくとも一区間に接触する第3後面接触部(52b)と、前記第3前面接触部(52a)と前記第3後面接触部(52b)との間に備えられ、前記内周面(12)から離隔する空間を形成する変形促進溝(52c)とを含む連結手段(50);及び
前記連結手段(50)に連結される眼内レンズ(30);を含み、
前記眼内レンズ(30)は、オプティック部(31)から放射状に突出するハプティック部(32)が備えられ、
前記連結手段(50)の内周面には、前記ハプティック部(32)が固定される溝(54)が備えられ、
さらに、前記連結手段(50)の前記変形促進溝(52c)が開始する地点は、赤道からの直線距離(L2)が0.9〜1.3mmをなす前記外周面(11)の一箇所に対向する位置に形成され、前記溝(54)の底面から前記変形促進溝(52c)までの間隔(d2)が0.4〜1.1mmをなす眼内レンズ組立体。 - 前記ハプティック部(32)の末端には、凸部(33b)と凹部(33a)が備えられ、前記溝(54)には、前記凸部(33b)に対応する断面を有する凹部(54a)と、前記凹部(33a)に対応する断面を有する凸部(54b)とが備えられる、請求項1に記載の眼内レンズ組立体。
- 前記連結手段(50)は、
リング状をなすリング部(51)と;
前記リング部(51)から放射方向に突出し、内周面に前記溝(54)が備えられた安着部(53)と;
前記安着部(53)から前記眼内レンズ支持体(10)の内周面に密着するように拡張された断面を有するように突出し、赤道付近に前記変形促進溝(52c)が設けられた拡張部(52)と;を含む、請求項2に記載の眼内レンズ組立体。 - 前記眼内レンズ支持体(10)は、前記第1前面接触部(11a)の一部区間に、運動伝達能力が向上できるように中心部に向かって陥没した複合運動伝達面(20)が備えられる、請求項1に記載の眼内レンズ組立体。
- 前記複合運動伝達面(20)は正面投影の際に直線断面をなす、請求項4に記載の眼内レンズ組立体。
- 前記複合運動伝達面(20)は正面投影の際に弧状断面をなす、請求項4に記載の眼内レンズ組立体。
- 前記眼内レンズ支持体(10)を前記水晶体嚢に装着した状態で、前記複合運動伝達面(20)は第2小帯付(7b)の付近に位置する、請求項4に記載の眼内レンズ組立体。
- 前記第1前面接触部(11a)に形成される前記複合運動伝達面(20)は、赤道からの長さ0.9mm〜1.5mmの区間に位置する、請求項7に記載の眼内レンズ組立体。
- 前記第1後面接触部(11b)に形成される前記複合運動伝達面(20)は、赤道からの長さ1.2mm〜1.9mmの区間に位置する、請求項7に記載の眼内レンズ組立体。
- 前記眼内レンズ支持体の内周面(12)は、赤道部に向かって陥没した断面形状をなし、
前記内周面(12)は、
前記赤道部から前記第1前面接触部(11a)の末端に向かって少なくとも一部の区間が弧状をなすように延びる第2前面接触部(12a)と;
前記赤道部から前記第1後面接触部(11b)の末端に向かって少なくとも一部の区間が弧状をなすように延びる第2後面接触部(12b)と;を含む、請求項4に記載の眼内レンズ組立体。 - 前記第1前面接触部(11a)、前記第1後面接触部(11b)、前記第2前面接触部(12a)、前記第2後面接触部(12b)の各弧は、楕円の一部区間をなし、
このとき、各弧をなす各楕円の短軸は、第1前面接触部(11a)が第1後面接触部(11b)よりも短く、第2前面接触部(12a)が第2後面接触部(12b)よりも短く形成される、請求項10に記載の眼内レンズ組立体。 - 各弧をなす各楕円の短軸は、前記第2後面接触部(12b)が最も長く、前記第1前面接触部(11a)が最も短く形成される、請求項11に記載の眼内レンズ組立体。
- 前記第1後面接触部(11b)の一部区間には、運動伝達能力が向上できるように中心部に向かって陥没した複合運動伝達面(20)がさらに含まれる、請求項4に記載の眼内レンズ組立体。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2015-0076716 | 2015-05-29 | ||
KR1020150076716A KR101718075B1 (ko) | 2015-05-29 | 2015-05-29 | 안구내 렌즈 조립체 |
PCT/KR2015/005671 WO2016195143A1 (ko) | 2015-05-29 | 2015-06-05 | 안구내 렌즈 조립체 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019073263A Division JP6821736B2 (ja) | 2015-05-29 | 2019-04-08 | 眼内レンズ組立体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018519981A JP2018519981A (ja) | 2018-07-26 |
JP6595102B2 true JP6595102B2 (ja) | 2019-10-23 |
Family
ID=57442319
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018514750A Expired - Fee Related JP6595102B2 (ja) | 2015-05-29 | 2015-06-05 | 眼内レンズ組立体 |
JP2019073263A Active JP6821736B2 (ja) | 2015-05-29 | 2019-04-08 | 眼内レンズ組立体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019073263A Active JP6821736B2 (ja) | 2015-05-29 | 2019-04-08 | 眼内レンズ組立体 |
Country Status (7)
Country | Link |
---|---|
US (1) | US10758339B2 (ja) |
EP (1) | EP3305250B1 (ja) |
JP (2) | JP6595102B2 (ja) |
KR (1) | KR101718075B1 (ja) |
CN (1) | CN107847313B (ja) |
ES (1) | ES2928394T3 (ja) |
WO (1) | WO2016195143A1 (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2952809C (en) | 2014-06-19 | 2019-11-26 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
US9358103B1 (en) | 2015-02-10 | 2016-06-07 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
JP6820271B2 (ja) | 2015-04-03 | 2021-01-27 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイトTHE REGENTS OF THE UNIVERSITY OF COLORADO,a body corporate | 眼球レンズ嚢の安定化ならびに白内障手術後の人工眼内レンズインプラントの回転を防ぐためのデバイスおよび方法 |
US10561493B2 (en) | 2015-04-03 | 2020-02-18 | The Regents Of The University Of Colorado, A Body Corporate | Lens capsule tension devices |
EP3463189B1 (en) | 2016-06-06 | 2023-01-18 | Omega Ophthalmics LLC | Prosthetic capsular device |
US10548719B2 (en) | 2017-03-01 | 2020-02-04 | Eye-Pcr B.V. | Devices for reconstruction of a lens capsule after cataract surgery |
WO2019195587A1 (en) | 2018-04-06 | 2019-10-10 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
JP7511218B2 (ja) * | 2019-10-17 | 2024-07-05 | 株式会社Mirai Eye | 調節眼内レンズ |
KR102306886B1 (ko) * | 2019-10-18 | 2021-09-30 | 주식회사 로섹 | 안구내렌즈 |
WO2021209955A1 (en) * | 2020-04-16 | 2021-10-21 | Alcon Inc. | Multi-part iol with stable iol base design to support a second optic |
EP4225211A1 (en) | 2020-10-12 | 2023-08-16 | Omega Ophthalmics LLC | Prosthetic capsular devices, systems, and methods |
KR20240053798A (ko) * | 2022-10-18 | 2024-04-25 | 주식회사 로섹 | 안구내렌즈용 연결지지체 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6013101A (en) * | 1994-11-21 | 2000-01-11 | Acuity (Israel) Limited | Accommodating intraocular lens implant |
US5628798A (en) * | 1996-03-18 | 1997-05-13 | Harry C. Eggleston | Adjustable and removable intraocular lens implant |
FR2784575B1 (fr) * | 1998-10-15 | 2000-12-22 | Megaoptic Gmbh | Implant intraoculaire accommodatif |
US20050085907A1 (en) * | 2000-02-16 | 2005-04-21 | Humanoptics Ag | Intraocular implant and an artificial lens device |
US6960231B2 (en) * | 2003-07-14 | 2005-11-01 | Alcon, Inc. | Intraocular lens system |
JP2008544819A (ja) * | 2005-07-01 | 2008-12-11 | ビジョン メンブレイン テクノロジーズ, インコーポレイテッド | 適合可能な支持部構造を有する折り畳み可能な眼内レンズ |
US20120330415A1 (en) * | 2011-06-23 | 2012-12-27 | Anew Optics, Inc. | Haptic devices for intraocular lens |
US8034106B2 (en) * | 2007-02-02 | 2011-10-11 | Adoptics Ag | Interfacial refraction accommodating lens (IRAL) |
KR100807940B1 (ko) * | 2007-03-08 | 2008-02-28 | 박경진 | 안구내렌즈 |
KR100807939B1 (ko) * | 2007-03-08 | 2008-02-28 | 박경진 | 안구내렌즈 조립체 |
KR100843454B1 (ko) | 2007-03-08 | 2008-07-03 | 박경진 | 안구내렌즈 지지체 |
US8414646B2 (en) * | 2007-12-27 | 2013-04-09 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
EP2384167A4 (en) * | 2009-01-09 | 2016-02-17 | Powervision Inc | INTRAOCULAR LENSES AND METHODS FOR TAKING INTO ACCOUNT CAPSULE DIMENSION VARIABILITY AND POST-IMPLANTATION CHANGES IN THE EYE |
WO2010091420A1 (en) * | 2009-02-09 | 2010-08-12 | Whitsett Jeffrey C | Exchangeable intraocular lens device and method of use |
CA2766655C (en) * | 2009-06-26 | 2017-10-10 | Abbott Medical Optics Inc. | Accommodating intraocular lenses |
US9186243B2 (en) * | 2011-05-31 | 2015-11-17 | Novartis Ag | Accommodative intraocular lens and method of implantation |
US9364318B2 (en) * | 2012-05-10 | 2016-06-14 | Z Lens, Llc | Accommodative-disaccommodative intraocular lens |
DE102012016893A1 (de) * | 2012-08-24 | 2014-05-15 | Be Innovative Gmbh | Intraokularlinse, insbesondere Kapselsackintraokularlinse |
US9339375B2 (en) | 2012-12-17 | 2016-05-17 | Novartis Ag | Capsule expander devices, systems, and methods for inhibiting capsular opacification and stabilizing the capsule |
JP5481588B1 (ja) * | 2013-05-13 | 2014-04-23 | 株式会社Frontier Vision | 調節眼内レンズ |
-
2015
- 2015-05-29 KR KR1020150076716A patent/KR101718075B1/ko active IP Right Grant
- 2015-06-05 ES ES15894316T patent/ES2928394T3/es active Active
- 2015-06-05 CN CN201580080505.6A patent/CN107847313B/zh active Active
- 2015-06-05 EP EP15894316.7A patent/EP3305250B1/en active Active
- 2015-06-05 US US15/578,199 patent/US10758339B2/en active Active
- 2015-06-05 JP JP2018514750A patent/JP6595102B2/ja not_active Expired - Fee Related
- 2015-06-05 WO PCT/KR2015/005671 patent/WO2016195143A1/ko active Application Filing
-
2019
- 2019-04-08 JP JP2019073263A patent/JP6821736B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
KR101718075B1 (ko) | 2017-04-04 |
WO2016195143A1 (ko) | 2016-12-08 |
JP2019130376A (ja) | 2019-08-08 |
US10758339B2 (en) | 2020-09-01 |
CN107847313B (zh) | 2020-12-01 |
KR20160140279A (ko) | 2016-12-07 |
EP3305250A1 (en) | 2018-04-11 |
CN107847313A (zh) | 2018-03-27 |
JP2018519981A (ja) | 2018-07-26 |
US20180147049A1 (en) | 2018-05-31 |
EP3305250B1 (en) | 2022-07-20 |
JP6821736B2 (ja) | 2021-01-27 |
EP3305250A4 (en) | 2019-03-13 |
ES2928394T3 (es) | 2022-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6595102B2 (ja) | 眼内レンズ組立体 | |
JP5628235B2 (ja) | 眼内レンズ支持体 | |
JP5091259B2 (ja) | 眼内レンズ組立体 | |
US8603165B2 (en) | Intraocular lens | |
CN101861133B (zh) | 调节型人工晶状体系统 | |
TW201632151A (zh) | 雙鏡片、曲率變化調節式iol | |
KR20080084815A (ko) | 원근 조절형 안내 렌즈 | |
JP2011502713A5 (ja) | ||
MXPA02004423A (es) | Sistema de lente intraocular. | |
US11877924B2 (en) | Ophthalmic devices, system and methods that improve peripheral vision | |
KR101718074B1 (ko) | 안구내렌즈 지지체 | |
US11833029B2 (en) | Intraocular optic assembly | |
US20230363889A1 (en) | Accomodating intraocular optic assemblies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171205 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181019 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181106 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190205 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20190405 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20190405 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190408 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190417 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190910 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190925 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6595102 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |